Japan Animal Referral Medical Center raises full-year forecast after strong half

Japan Animal Referral Medical Center reported strong consolidated financial results for the second quarter ended September 30, 2025, with net sales reaching JPY 3,033,666 thousand, an 18.1% increase year-over-year. Operating profit surged by 68.4% to JPY 591,051 thousand, and ordinary profit rose by 67.5% to JPY 589,735 thousand. Net income attributable to shareholders saw a 70.2% increase, totaling JPY 413,268 thousand. Basic earnings per share for the interim period were JPY 159.88.

Following this strong performance, the company revised its full-year consolidated earnings forecast for the fiscal year ending March 2026. The revised forecast projects net sales of JPY 6,100 million, up from JPY 5,960 million. Operating profit is now expected to be JPY 1,040 million, an increase from JPY 857 million, and ordinary profit is forecast at JPY 1,030 million, also up from JPY 857 million.

Net income attributable to shareholders for the full year is revised to JPY 730 million from JPY 610 million, with basic earnings per share projected at JPY 282.42. The company attributes the upward revision to sustained high demand for secondary animal medical care, optimized treatment processes, enhanced treatment quality, and expanded capacity through investments in human capital, medical equipment, and digitalization. The interim dividend remained at JPY 0.00, and the year-end dividend forecast is JPY 40.00 per share.